A detailed history of Regentatlantic Capital LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 1,071 shares of CRL stock, worth $198,552. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,071
Previous 1,147 6.63%
Holding current value
$198,552
Previous $245,000 13.88%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $13,865 - $19,041
-76 Reduced 6.63%
1,071 $211,000
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $234,137 - $346,852
1,147 New
1,147 $245,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.43B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.